Purification of α1 proteinase inhibitor from human plasma fraction IV-1 by ion exchange chromatography

Vox Sanguinis

Volumn 74, Issue 4, 1998, Pages 232-241

  Chen, Sharon X ^a,b   Hammond, David J ^a   Lang, John M ^a   Lebing, Wytold R ^b  

^a Research and Development   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; EMPHYSEMA; HEAT; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LUNG INJURY; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PURIFICATION; VIRUS INACTIVATION;

ALPHA 1-ANTITRYPSIN; ANIONS; BLOOD PROTEINS; CATIONS; CHOLATES; CHROMATOGRAPHY, DEAE-CELLULOSE; CHROMATOGRAPHY, ION EXCHANGE; DETERGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR WEIGHT; PHOSPHORIC ACID ESTERS; PILOT PROJECTS; PROTEIN STRUCTURE, TERTIARY; SODIUM DODECYL SULFATE; SOLVENTS; STERILIZATION; TEMPERATURE; VIRUS ACTIVATION; VIRUSES; WATER;

EID: 0031879010     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030941     Document Type: Article

References (34)

1. 1-Antitrypsin as a recent example. Am J Physiol 1993;265:L211-L219.
2. Beatty K, Bieth J, Travis J: Kinetics of association of serine proteinases with native and oxidized α-1 proteinase inhibitor and α-1 antichymotrypsin. J Biol Chem 1980:255:3931-3934.
3. 53 → Phe), further evidence for intracellular loopsheet polymerization. J Biol Chem 1993;268: 15333-15335.
4. 1-antitrypsin. Pharm Biotechnol 1993;5:263-286.
5. Drobnies AE, Vaughan R: Alpha-1 antitrypsin protease inhibitor typing in immobilized pH gradients. Ann Clin Lab Sci 1993;23:33-38.
6. 1 -proteinase inhibitor. Biochemistry 1993;32: 9230-9235.
7. Barker AF, Seimsen F, Pasley D, D'Silva R, Sonia A: Replacement therapy for hereditary alpha 1-antitrypsin deficiency. Chest 1994;105: 1406-1410.
8. Report of a World Health Organization: Alpha-1-antitrypsin deficiency. Human genetics program, division of noncommunicable diseases, Geneva, 1996.
9. 1,-antitrypsin. Nature 1982:298:329-333.
10. 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 1984;177:531-556.
11. 1-antitrypsin reveals the conformation of its inhibitory reactive loop. FEBS Lett 1995;377:150-154.
12. 1-proteinase inhibitor probed by limited proteolysis. Biochemistry 1992-31:2720-2728.
13. Bollen AJ, Chuchans P, Hoylaerts M: Alpha-1 antiprotease purification. US Patent 1986;4: 629, 567.
14. Novikova LI, Kulidova NN, Aleshkin VA: The isolation of alpha 1-proteinase inhibitor from the by products of the manufacture of blood products. Gematol Transfuziol 1989;35:96-99.
15. Posiarene SM, Letskene MN, Mauritsas MM, Planchiunen RR: Immunoaffinity purification of alpha 1 protease inhibitor from human plasma. Vopr Med Khim 1989;35:96-99.
16. 1-antitrypsin concentrate. Vox Sang 1987;52:291-297.
17. 1 ,-proteinase inhibitor (human). Eur Respir J Suppl 1990;9:16s-20s.
18. Dubin A, Potempa J, Travis J: Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography. Prep Biochem 1990:20:63-74.
19. 1-antitrypsin. US Patent 1966;3:293, 236.
20. 1,-Proteinase inhibitor deficiency; in Massaro D (ed): Lung Cell Biology. Dekker, New York 1989, pp 1227-1246.
21. Ballieux BE, Hagen EC, van-der-Keur C, Zegers ND, van-Es LA, van-der-Woude FJ, Daha MR: Isolation of a protein complex from purulent sputum consisting of proteinase-3 and alpha 1-antitrypsin reactive with anti neutrophil cytoplasmic antibodies. J Immunol Methods 1993; 159:63-70.
22. Paul Ehrlich Institute: Decrease of the risk of transmission of hematogcnous viruses in pharmaceutical products which are manufactured from plasma of human origin. Fed J, August, 1994.
23. Lebing WR, Hammond DJ, Wydick JE III, Baumbach GA: A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography. Vox Sang 1994;67: 117-124.
24. Hoffman DL: Purification and large-scale preparation of antithrombin III. Am J Med 1989; 87(suppl 3B):23S-26S.
25. Layne E: Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol 1957;3:450-451.
26. Cramer SM: Displacement chromatography. Nature 1991;351:251-252.
27. Piszkiewicz D, Thomas W, Lieu MY, Tse D, Sarno L: Virus inactivation by heat treatment of lyophilized coagulation factor concentrates; in Morgenthaler JJ (ed): Virus Inactivation in Plasma Products. Curr Stud Hematol Blood Transfus. Basel, Karger 1989, vol 56, pp 44-54.
28. 1protease inhibitor by a unique procedure designed for industrial application. Anal Biochem 1982:124:364-371.
29. 1-antitrypsin respectively prealbumin. Immunochemistry 1974; 11:703-709.
30. 1-proteinase inhibitor affecting its cholesterol binding ability, FEBS Lett 1993; 323:236-238.
31. 1,-antitrypsin: Molecular structure and the PI system. Acta Paediatr 1994;83(suppl 393):1-4.
32. Schmid K: Preparation and properties of serum and plasma proteins. XXIX. Separation from human plasma of polysaccharides, peptides and proteins of low molecular weight. Crystallization of an acid glycoprotein. Am Chem Soc J 1953;75:60-68.
33. 1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur J Biochem 1990;194:51-56.
34. 1-antitrypsin accumulation in the liver. Nature 1992;357:605-607.